Susquehanna International Group, LLP Aditxt, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.13 - $0.46 $9,919 - $35,098	-76,300 Reduced 45.99%	89,600 $13,000
Q1 2022 May 16, 2022	SELL	$0.34 - $0.58 $26,758 - $45,646	-78,700 Reduced 32.17%	165,900 $76,000
Q4 2021 Feb 14, 2022	BUY	$0.54 - $2.51 $80,622 - $374,742	149,300 Added 156.66%	244,600 $132,000
Q3 2021 Nov 15, 2021	SELL	$1.54 - $3.04 $180,026 - $355,376	-116,900 Reduced 55.09%	95,300 $161,000
Q2 2021 Aug 11, 2021	SELL	$2.2 - $3.2 $147,400 - $214,400	-67,000 Reduced 24.0%	212,200 $550,000
Q1 2021 May 17, 2021	BUY	$2.08 - $5.26 $580,736 - $1.47 Million	279,200 New	279,200 $712,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $2.21M
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.